Anti-GALNT14 monoclonal antibody

Pre-made anti-GALNT14 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GALNT14/GALNT14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0881-Ab-1/ GM-Tg-hg-IP0881-Ab-2Anti-Human GALNT14 monoclonal antibodyHuman
GM-Tg-rg-IP0881-Ab-1/ GM-Tg-rg-IP0881-Ab-2Anti-Rat GALNT14 monoclonal antibodyRat
GM-Tg-mg-IP0881-Ab-1/ GM-Tg-mg-IP0881-Ab-2Anti-Mouse GALNT14 monoclonal antibodyMouse
GM-Tg-cynog-IP0881-Ab-1/ GM-Tg-cynog-IP0881-Ab-2Anti-Cynomolgus/ Rhesus macaque GALNT14 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0881-Ab-1/ GM-Tg-felg-IP0881-Ab-2Anti-Feline GALNT14 monoclonal antibodyFeline
GM-Tg-cang-IP0881-Ab-1/ GM-Tg-cang-IP0881-Ab-2Anti-Canine GALNT14 monoclonal antibodyCanine
GM-Tg-bovg-IP0881-Ab-1/ GM-Tg-bovg-IP0881-Ab-2Anti-Bovine GALNT14 monoclonal antibodyBovine
GM-Tg-equg-IP0881-Ab-1/ GM-Tg-equg-IP0881-Ab-2Anti-Equine GALNT14 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0881-Ab-1/ GM-Tg-hg-IP0881-Ab-2; GM-Tg-rg-IP0881-Ab-1/ GM-Tg-rg-IP0881-Ab-2;
GM-Tg-mg-IP0881-Ab-1/ GM-Tg-mg-IP0881-Ab-2; GM-Tg-cynog-IP0881-Ab-1/ GM-Tg-cynog-IP0881-Ab-2;
GM-Tg-felg-IP0881-Ab-1/ GM-Tg-felg-IP0881-Ab-2; GM-Tg-cang-IP0881-Ab-1/ GM-Tg-cang-IP0881-Ab-2;
GM-Tg-bovg-IP0881-Ab-1/ GM-Tg-bovg-IP0881-Ab-2; GM-Tg-equg-IP0881-Ab-1/ GM-Tg-equg-IP0881-Ab-2
Products NameAnti-GALNT14 monoclonal antibody
Formatmab
Target NameGALNT14
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GALNT14 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0881-Ag-1Recombinant multi-species GLT14/ GALNT14/ GALNT15 protein
    ORF Viral VectorpGMLPm003408mouse Galnt14 Lentivirus plasmid
    ORF Viral VectorvGMLPm003408mouse Galnt14 Lentivirus particle


    Target information

    Target IDGM-IP0881
    Target NameGALNT14
    Gene ID79623,71685,313878,705068,483025,101089934,540500,100070711
    Gene Symbol and Synonyms0610033M06Rik,GalNac-T10,GalNac-T14,GALNT14,GALNT15
    Uniprot AccessionQ96FL9
    Uniprot Entry NameGLT14_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000158089
    Target ClassificationN/A

    The target: GALNT14, gene name: GALNT14, also named as GALNT15, GalNac-T10, GalNac-T14. This gene encodes a Golgi protein which is a member of the polypeptide N-acetylgalactosaminyltransferase (ppGalNAc-Ts) protein family. These enzymes catalyze the transfer of N-acetyl-D-galactosamine (GalNAc) to the hydroxyl groups on serines and threonines in target peptides. The encoded protein has been shown to transfer GalNAc to large proteins like mucins. Alterations in this gene may play a role in cancer progression and response to chemotherapy. [provided by RefSeq, Jun 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.